Among individuals with a recent acute coronary syndrome (ACS) event, it has been recently documented that higher baseline IL-6 levels significantly increase the risk for MACE by 29% and the risk for cardiovascular death by 55%, pointing out the significant prognostic value of IL-6 in the ACS setting [27]. The gene discussed is IL6; the disease is acute coronary syndrome.